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INTRODUCTION 
Abdominal aortic aneurysm (AAA) is a common pathology, with an estimated 
incidence of 20 to 40 cases/100,000 persons per year,’V2 and its prevalence in adult 
autopsy series lies between 1 and 6%.3 In a recent English study, its prevalence 
is 2.6% in men aged 60 to 64, 6% for those aged 65 to 74 and 9% over 75.4 By 
ultrasound screening, Collin et al.’ found an abdominal aortic aneurysm in 5.4% 
of men aged 65 to 74,2.3% of them being 4 cm or more in diameter. In an epidemiol- 
ogical survey held in 1992 in England and Wales, AAA caused 1.9% of all deaths 
in men and 0.7% of all deaths in women aged 60 or over.6 The etiologies of 
aneurysmal dilatation are multiple. Some well-known causes are uncommon 
(Marfan syndrome, Ehlers-Danlos disease type IV, fibromuscular dysplasia) or 
historical (syphilis). The frequent coincidence of atherosclerosis and the presence 
of an abdominal aortic aneurysm has led to the opinion that the aneurysm might 
be a consequence of atherosclerosis. Some facts derived from the clinical observa- 
tion are, however, incompatible with a direct causal relationship between aneu- 
rysms and atherosclerosis7 and suggest that atherosclerosis is either coincidental 
or facilitating. AAA is frequent in the elderly. The familial clustering of cases has 
only recently drawn attention. Since the first case report by Martin Clifton, in 
1977,8 several series have confirmed AAA as one of the most frequent “familial” 
diseases. It appears probable that “not everyone is prone to aneurysm” and that 
a particular genetic character predisposes the aging arterial wall to an aneurysmal 
transformation, perhaps in response to an accidental factor. Although some de- 
scriptive statistics are available on the familial aspects and on the natural history 
of the disease, the pathogeny and the genetic background still remain largely 
obscure, and each mode of inheritance (dominant, recessive, X-linked, multifacto- 
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AAA: WHO IS AFFECTED? 
In familial studies, persons have to be assigned a status: affected, unaffected, 
or unknown. Whereas this is of little concern for congenital, qualitative defects, 
the determination of the affection status is a major difficulty in the study of AAA 
families. 
An aneurysm can be defined as an abnormal, permanent, and irreversible local- 
ized dilatation of a vessel. If this definition allows straightforward diagnosis of 
large aneurysms, it is ambiguous for the smaller ones. The precision of the defini- 
tion is important to decide what is considered or rejected as infrarenal AAA, 
and may have unsuspected effects on segregation analysis and epidemiological 
studies.1° Some clinicians consider that an aneurysm is present when the largest 
axis of the infrarenal aorta exceeds an absolute diameter ranging from 3 to 4 cm, 
or when dilatation exceeds 50% of the diameter of the normal aorta for the sex 
and the height of the patient. Others use a ratio of the diameters of the infrarenal 
and suprarenal aorta exceeding a threshold varying from I .5 : 1 to 2: I .  
Aneurysms are pathological dilatations of vessels progressively worsening with 
time, thus delayed in their appearance. They can affect any arterial segment of 
the organism but they are most often seen at the arterial structural weak points: 
transition zones between the fixed aorta and the free aorta and flexion zones. 
They can be unique or multiple in the same patient. The majority of clinically 
detectable aneurysms are found in the infrarenal abdominal aorta. They often 
extend along the common iliac artery, and, more rarely, on the external iliac artery. 
Aneurysms of the popliteal arteries are frequently associated with aneurysms of 
the infrarenal aorta, and aneurysms of cerebral arteries are also observed with an 
increased frequency in patients or relatives of AAA patients'' (6 of 313 in our 
experience). In AAA patients, there could be a generalized tendency to peripheral 
artery dilatation. I 2  The delayed appearance, the multiplicity of sites, and the met- 
achronous development of arterial aneurysms obviously complicate the status 
assignment of individuals in pedigree studies and the comparison between series. 
SEEKING POPULATION-BASED EPIDEMIOLOGICAL DATA 
Despite the huge number of publications on AAA, we still lack detailed epide- 
miological data on nonruptured AAA. Bickerstaff er a/. '  computed incidences of 
AAA by age group in a general population. Their values have been converted to 
cumulative incidences by Majumder er d . I 3  Data were collected between 1951 
and 1980, and concern the predominantly white population of Rochester, Minne- 
sota. AAA patients were gathered from all sources, including diagnosis "by 
chance" and necropsic discovery of unsuspected patients, but not on ultrasound 
(US) scan, so that underestimation is still likely. All cases of ruptured AAA were 
collected by Bengtsson for the period 1971-1986 in Malmo, Sweden.I4 Other re- 
cent epidemiological studies are available, possibly showing a trend toward an 
increase in age-standardized incidence of AAA in northern E h r ~ p e . ~ . " . ' ~  Whether 
this reflects a true modification in the incidence, or illustrates better awareness 
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and better (and earlier) diagnosis thanks to modem imaging techniques is not 
certain, but represents a real problem for all population-based genetic analysis. 
AAA IN SIBSHIPS: THE EMERGENCE OF A FAMILIAL DISORDER 
Clifton,s reporting three affected brothers in 1977, pioneered the study of famil- 
ial aggregation of AAA. Johansen and Koepsell” compared the family histories 
of 250 patients with AAA to those of 250 control subjects. Among the latter, 2.4% 
reported a first-degree relative with an aneurysm, compared with 19.2% of the 
patients with AAA, representing a 11.6-fold increase in risk among persons with 
an affected first-degree relative. Darling et a1.I’ found 15.1% of proband with an 
affected first-degree relative as compared to 1.8% of a control group of 500 patients 
of similar age and sex. Several other series were p u b l i ~ h e d , ” ~ ’ ~ - ~ ~  including our 
own systematic analysis of 313 pedigrees.23 The series are compared in TABLE 1. 
The sex ratio in favor of males varies between 4: 1 and 20: 1. Based on nonsystem- 
atic clinical diagnosis, the proportion of AAA proband with a positive family 
history goes from 12 to 20%, and the relative risk of AAA for siblings was 10 to 
20%. Webster et al.’ found 16.2% of familial AAA history by anamnesis of 43 
consecutive patients. After prospective US screening, the number of familial cases 
rose to 27.9%. Bengtsson et ~ 1 . ’ ~  found 29% of AAA in male and 6% in female 
relatives after US screening, confirming the extremely high incidence of cryptic, 
asymptomatic familial AAA. These discrepancies leave much room for doubt as 
to the accuracy of older epidemiological studies of AAA. Differences in natural 
history of AAA depending on the familial history were addressed in larger series. 
In the Darling et al. study,Is no significant difference was found between the 
patients with nonfamilial and familial AAA in anatomic extent, or associated occlu- 
sive disease. Patients with familial AAA were more likely to be women (35 vs. 
14%), and, men, in their group, were affected about five years earlier than women. 
TABLE 1. Comparison of Familial Studies of 
Norrgard Tilson Johansen 
Pedigrees 
N 87 (initially 200) 50 250 
Multiplex 18 (20.6%) 50 48 (19.2%) 
Horizontal 10 28 18 
Vertical/complex 8 22 > 19 
AAA 103 127 2307 
AAA (familial subgroup) 38 127 2 105 
Sex ratio (M/F) 155:45 (3.75: I )  ? 207:43 (4.81:l) 
Familial 30:8 (3.75:l) 11 : 16 (6.94: 1) ? 
Sporadic ? ? ? 
Age at diagnosis 67 (M66/F70) ? 72 
Familial 65 ( n  = 19) ? ? 
Sporadic ? ? ? 
Rupture rate 68/200 (initial) ? ? 
Familial 14/38 (36.8%) ? ? 
Sporadic ? ? ? 
VERLOES et al.: GENETIC ASPECTS OF AAA 41 
The risk of rupture was strongly correlated with familial disease and the presence 
of a female member with aneurysm (63 vs. 37%). In our own study of 3 13 pedigrees, 
we found similar differences: the age at diagnosis two years earlier ( p  < 0.05) and 
the age at rupture 10 years earlier ( p  < 0.001) in males of multiplex pedigrees, as 
well as the rupture rate were higher in the latter (32.4 vs. 8.7%). Ethnic differences 
in AAA have been considered by Johnson et a1.2s in a survey of autopsies and 
abdominal CT scans: white males have a frequency of abdominal aortic aneurysm 
about three times that in black males, black females, or white females; all three 
of the latter groups had comparable frequencies. 
AAA IS A GENETIC DISEASE 
Genetic aspects of AAA have been the subject of very few studies. Because 
of the irregular clustering of cases, some authors inferred it was multifactorial.’6 
Tilson and Seashore’” presented 50 families, including three pairs of identical 
twins. Those families were collected by various teams, and no data were given 
either on the mode of ascertainment or on the isolated AAA from the same popula- 
tion. Twenty-nine of 50 were single-generational, 18 showed simple “vertical” 
transmission, and 3 were “complex.” In an empirical approach to the results, 
they favored a frequent X-linked dominant form and a less common autosomal 
dominant, or a multifactorial model. Norrgard et al.” illustrated several pedigrees. 
Familial AAA Does Not Respect Simple Pattern 
Whereas the determination of a mode of inheritance does not require sophisti- 
cated analysis for rare, fully penetrant, qualitative disorders of early onset (such 
as cystic fibrosis or hemophilia), it can be a real problem for a common disorder 
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with irregular familial expression. Irregular familial aggregation may result from 
partially and/or age-dependent penetrance of one or several rare dominant, or 
frequent recessive genes (Mendelian inheritance patterns), from additive effects 
of several genes (polygenic inheritance) or environmental factors, or from a combi- 
nation of those effects (multifactorial inheritance). Then, the question whether a 
single identifiable locus accounts for a significant amount of the phenotypic varia- 
tion in a population may be addressed through the methodology of segregation 
analysis. 
Experimental Approach 
The Blotchy mouse2' shows a decreased resistance of the skin and a propensity 
to AAA related to a mutation on chromosome X. This deficiency in cross-linking 
of collagen and elastin is biochemically related to a decrease in the conversion of 
lysine to lysine-aldehyde residues. This congenital biochemical defect is close to 
the pathology of aneurysms produced in the turkey2* and mouse29 by administra- 
tion of lathyrogens, which prevent the formation of aldehydes by inactivating lysyl 
oxidase. Experimental deficiency in copper, which is a cofactor of lysyl-oxidase, 
can induce aneurysms in the pig and in the chicken. Although those experiments 
are significant models for inborn defects in AAA formation, caution is advisable 
before extrapolation to the human condition for two reasons. First, the aneurysmal 
transformation takes several decades in man whereas in animal models it requires 
a relatively short time; second, the composition of the aorta in terms of fibrous 
protein is not perfectly similar in man and animals. 
Formal Genetics Approach 
Most studies of common diseases assume that genetically determined factors 
are numerous and give an equal and individually small contribution to the pheno- 
type. In polygenic models, a quantitative trait (with threshold) or a qualitative 
trait result from additive effects of several biallelic (A,a) loci. Each locus has an 
even-weighted effect. Loci are unlinked (independent transmission), and heterozy- 
gotes ( A a )  contribute an effect which is intermediate between the effects of both 
types of homozygotes (AA, aa). Each locus accounts for a part in the genetic 
variance of the population. The parent-child and child-child correlations are 50% 
for each locus. In those models, formal genetic analysis is limited to the computa- 
tion of heritability, which is the proportion of total phenotypic variance due to 
polygenic effects. Assuming a multifactorial model, Powell and Greenhalgh26 cal- 
culated a heritability of 70%, using Falconer's method, for a series of 60 patients, 
25 of them with positive familial history. 
Segregation analysis is basically the comparison of the observed proportion of 
affected offspring with the expected proportion according to a particular genetic 
hypothesis. To assess evidence of a major gene effect in the presence of other 
familial sources of correlation (polygene, sociocultural factors, etc.), pedigrees 
may be analyzed using the pointer ~trategy.~' This methodology was developed 
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as a tool for analysis of multigenerational pedigrees and is based on the mixed 
model, a mathematical model combining genetic and multifactorial compo- 
n e n t ~ . ~ ' - ~ ~  It includes modifiable parameters, which allow the definition of several 
submodels (purely dominant, multifactorial, etc.). The likelihood of the observed 
sibships conditional on the phenotype of the parents is computed and maximized 
through fine-tuning of those transmission parameters. The likelihood of the general 
model (mixed) is compared with appropriate statistical tests to restricted submod- 
els, the best model being the more likely, or, for nonsignificantly differing submod- 
els, the most parsimonious in terms of parameters. Cumulative incidence of the 
trait in the population (stratified, if necessary, for age and sex in several subgroups) 
and ascertainment probability of the sample must be known. It implies that reliable 
epidemiological data are available for the studied population. Genetic heterogene- 
ity cannot be directly addressed by this mode of analysis. 
Two teams have attempted segregation analysis of AAA. In Majumder et a / . ' s  
~ o r k , ' . ' ~ . ~ ~  data on first-degree relatives of 91 probands from 91 pedigrees were 
collected (sex ratio 79: 12). Cases with patent AAA (thus probably > 50 mm) were 
considered as positive. Their number of multiplex pedigrees was relatively small 
(13 of 91). The most likely genetic model was an autosomal diallelic locus with a 
recessively inherited gene for AAA. A multifactorial component did not increase 
significantly the likelihood of the data set. In our own analysis of 324 probands 
(sex ratio 312: 12) from 313 pedigrees (including 39 multiplex families), we used 
a less drastic definition: infrarenaVsuprarena1 ratio > 1.5 or absolute diameter 
> 30 mm. Our analysis favored a simple autosomal dominant model, with a carrier 
frequency of 1 of 250 and a age-related penetrance never higher than 0.4, even in 
the subgroup of elder men. Like Majumder et a / . ,  we noted that a multifactorial 
component did not lead to a significantly better fit.  Whether differences in the 
inheritance mode between the two studies come from differing ascertainment, 
variable definitions of the affected status, or differing local epidemiology (sus- 
pected on the basis of our unusually high sex ratio) remains unknown. Neverthe- 
less, the importance of a single genetic factor in the appearance of AAA remains 
the most important lesson resulting from those formal genetic works. The differ- 
ence between sexes may nevertheless indicate that an adjuvant factor (hyperten- 
sion, atheromatosis) may act as a modifier on penetrance and/or expressivity of 
the disease. 
Candidate Gene Approach 
Both clinical considerations and experimental results allow suspect genes in- 
volved in the constitution of the normal matrix and in its turnover to play a role 
in the genetic background of aneurysmal predisposition. Among structural compo- 
nents of the conjunctive intercellular matrix are collagens, genes of the matrix 
metalloproteinases family (including the chromosome 11q22-23 collagenase cluster 
members), the tissue inhibitors of metalloproteinases), and two genes, HP and 
CETP, that map in the vicinity of CLG4A (although the latter two are not primarily 
involved in matrix m e t a b ~ l i s m ~ ~ ) .  They are listed in TABLE 2. 
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TABLE 2. Candidate Mapped Genes for Abdominal Aortic Aneurysm 
Chromosome 
Gene Synonyms Gene Symbol(s) Location 
Matrix proteins 
Al-chains of collagen type 1 COLlAl  17q22 
A2-chains of collagen type I COLlA2 7q22. I 
A-chain of collagen type Ill  COWA I 2q3 1 
Fibrillin 1 FBNl 15q21.1 
Elastin ELN 7q11.2 
Collagenase A type IV MMP;! 72 kDa gelatinase 16q13 
Degradation enzymes 
CLG4A 
Gelatinase B MMP9 92 = kDa gelatinase 20q 1 1-13 
Interstitial collagenase CLG/MMP I I lq22-23 
Matrily sin PUMPI/MMW 1 lq22-24 
Collagenase 3 CLG3/MMP 13 1 lq22-23 
Stromelysin 1 STMY/MMP3 1 lq22-23 
Stromelysin 2 STMY2/MMP 10 11q22-23 
CLG4B 
Neutrophil collagenase CLGI/MMP8 1 lq2 1-22 
Degradation inhibitors 
Metalloproteinase inhibitor type 2 TIMP2 17q25 
Chromosome 16 candidates 
Cholesterol-ester transfer protein CETP 16q21 
Haptoglobin alpha chain H P  16q2 1 
Metalloproteinase inhibitor type 1 TIMPIIHCIIEPA Xpll .1 
Collagen Genes 
All cell types of the vascular wall are actively engaged in the synthesis of colla- 
gen. Collagens types I and 111 are the main varieties found in the arterial wall. 
Collagen IV is found in basal membranes. Defects of collagen I chains are well 
known in all forms of osteogenesis imperfecta, in which no vascular problem 
arises. Type I11 collagen is localized in the subendothelial space, and both types 
I and I11 are present in the media. In human thoracic aorta, abdominal aorta, and 
carotid artery approximately 50-75% of total collagen in the media consists of 
type I collagen. Interstitial collagens type I and 111 (and the minor type V) are 
synthesized by the fibroblasts of the adventitia. The post-translational hydroxyla- 
tion of some prolyl residues allows the association of three a-chains in a stable 
triple helix structure that subsequently polymerize spontaneously to form the “in- 
terstitial fibers,” highly resistant to proteolysis. Type I and type 111 collagens 
make hybrid fibers surrounding a central core of type V. Other types of collagen 
have also been described in the vascular wall: type VI collagen and type VIII 
(which could serve as a bridge between the collagen fibers and the noncollagen 
components). Each of those constituents of the collagen bundles may be a candi- 
date for some cases of familial AAA. 
suggested that a deficiency of type 111 collagen might be 
the basis for the aneurysm formation. Menashi er al.36 showed a low content of 
type I11 collagen in a group of patients with familial AAA. Minor normal allelic 
Loosemore et 
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variants of COL3A1 were found in association with AAA. A less elastic aneurysm 
wall was found in those patients3’ Thermally unstable procollagen 111 was found 
in two patients with multiple aneurysms.38 Furthermore, mutations of collagen 
type 111 are known to occur in the vascular type IV of Ehlers-Danlos (EDIV).39 
Clinical hallmarks of EDIV include facial dysmorphism (pinched nose, thin lips), 
fragile, easily bruisable, translucent skin with prominent venous markings, mitral 
valve prolapse, microangiopathy of skin capillaries with microbleedings and mi- 
croaneurysms, tortuous arteries, AAA, and very commonly spontaneous arterial 
and bowel ruptures. In many families, EDIV is due to mutations of pro-alpha- 
chains of type I11 collagen. 
In 1990, Sirpa Kontusaari showed two single base mutations in COL3Al in 
two families with dominantly inherited AAA. In the first family, the mutation was 
shown to result in an amino acid substitution (GLY619ARG).40 In the second, 
presenting with AAA and easy bruisability, a single base mutation in intron 20 
(G+’  *vs20)41 was shown to induce aberrant splicing of the mRNA, hence reducing 
the synthesis of the crl(III) chain. This family is of peculiar clinical importance, 
as clinical presentations extended from the classical EDIV disease to isolated 
AAA. Tromp et ~ l . ~ *  carried out detailed DNA sequencing of the triple-helical 
domain of type I11 procollagen on cDNA from 54 patients with aortic aneurysms, 
43 of them with at least one affected relative. Only two amino acid substitutions 
were found (GLY 136ARG, THRsOIPRO), the second of unclear functional signifi- 
cance, thus indicating that collagen 111 mutations are not a major cause of common 
AAA. 
Elustin and Fibrillin 
Elastin is a fibrous protein, displaying a distribution in the vascular walls more 
restricted than that of collagen. The elastin fibers, by their abundance and their 
elasticity, are one of the most important constituents of the arterial wall. The 
smooth muscle cells synthesize medial elastin. It is organized in concentric lamel- 
lae in the media of the large arteries found near the heart, such as the aorta or 
pulmonary artery (so-called elastic arteries). The number of concentric lamellae 
appears to be genetically determined and a progressive decrease in their number 
is observed from the heart to the aorto-iliac bifurcation. Elastin is dramatically 
reduced in the AAA Tropoelastin, the soluble precursor of elastin, is rich 
in lysine, which is oxidized by a lysyl-oxidase into reactional aldehydes that con- 
dense to form desmosine and isodesmosine cross-links between four molecules. 
Without this bridging, elastin could not be elastic. The tropoelastin molecules are 
deposited into a microfibrillar structure containing fibrillin as the main component. 
Some types of ducks, particularly sensitive to aneurysmal transformation, are 
characterized by a lysyl-oxidase defect. Reduced synthesis of elastin may result 
from large mutations or larger deletions of the elastin gene region on chromosome 
7. In patients with deletions limited to the ELN gene, the phenotype is autosomal 
dominant supravalvular aortic ~ t e n o s i s , ” . ~ ~  whereas larger deletions led to the 
Williams-Beuren (“elfin facies”) syndrome.46 None of those phenotypes is associ- 
ated with AAA, but nothing is known about the phenotypic effect of missense 
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mutations of the elastin gene (which could interfere with cross-linking of tropelas- 
tin). Mutations in the fibrillin-1 gene are present in almost all families with Marfan 
~yndromes,4’*~~ a well-known disorder characterized, on the vascular field, by 
dilatation of the aortic root (prone to dissection or rupture) and valvular insuffl- 
ciency, but not by classical AAA. Nevertheless, the full spectrum of phenotypes 
associated with mutations of fibrillin-1 is still to be defined. 
Collugenases 
Collagenases are members of a group of secreted zinc metalloproteases, which 
degrade the collagens and other constituents of the extracellular matrix. Thus, 
increased activity, abnormal regulation or ectopic expression of those genes could 
affect the turnover of collagen fibrils. CLG4A, located on chromosome 16, is 
secreted from normal skin fibroblasts, whereas CLG4B, recently mapped on chro- 
mosome 20,49 is produced by normal alveolar macrophages and granulocytes. 
Both have closely resembling structures, with 13 exons including a fibronectin- 
like and are active on the basement membrane collagen IV. CLG4B 
digests collagen types I, 11,111, IV, and V, denatured collagen (gelatin), and elastin. 
At least four collagenase genes are located on chromosome 11: CLG1, CLG3, 
STMY, and STMY2.5’-53 CLGl is the only enzyme to initiate breakdown of colla- 
gens 1, 11, and 111. Association has been observed between the CLG4A region 
and AAA, but until now, no published linkage studies sustain a role of the other 
collagenases in the etiology of familial AAA. In a recent study, St Jean did not 
find disequilibrium linkage between an intragenic CLG4B microsatellite marker 
and the presence of AAA.49 
CONCLUSION 
AAA is a complex disorder with multiple risk factors and probably multiple 
pathogenetic pathways. The major determinant factors in the appearance of AAA 
appear to be genetic and behave usually as dominant traits. Several inborn defects 
of connective tissue matrix are candidates for AAA, although, until now, only a 
limited fraction of families have been shown to be linked to mutations of the 
COL3A1 gene. Linkage studies in selected pedigrees should lead to the unraveling 
of the basic pathogenesis in the near future. 
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